Arena Pharma (ARNA) Posts Narrower than Expected Q4 Loss
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
Arena Pharmaceuticals (NASDAQ: ARNA) reported Q4 loss of $0.23, $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $4.01 million versus the consensus estimate of $4.81 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
